Cargando…

Target Attainment and Clinical Efficacy for Vancomycin in Neonates: Systematic Review

Vancomycin is commonly used as a treatment for neonatal infections. However, there is a lack of consensus establishing the optimal vancomycin therapeutic regimen and defining the most appropriate PK/PD parameter correlated with the efficacy. A recent guideline recommends AUC–guided therapeutic dosin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mejías-Trueba, Marta, Alonso-Moreno, Marta, Herrera-Hidalgo, Laura, Gil-Navarro, Maria Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064372/ https://www.ncbi.nlm.nih.gov/pubmed/33805874 http://dx.doi.org/10.3390/antibiotics10040347

Ejemplares similares

Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review
por: Alonso-Moreno, Marta, et al.
Publicado: (2021)

Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review
por: Del Valle-Moreno, Paula, et al.
Publicado: (2023)

P30 Evaluating vancomycin continuous infusion protocol compliance and gauging therapeutic target attainment in neonates
por: Lewis, Francesca, et al.
Publicado: (2023)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
por: Bradley, Nicole, et al.
Publicado: (2023)

Attainment of therapeutic vancomycin level within the first 24 h
por: Honore, Patrick M., et al.
Publicado: (2019)

Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial
por: Gwee, Amanda, et al.
Publicado: (2018)

117 Evaluating Predicted vs. Actual Vancomycin Pharmacokinetic Target Attainment Using AUC Dosing
por: Boyd, Allison N, et al.
Publicado: (2022)

Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice
por: Villanueva-Bueno, Cristina, et al.
Publicado: (2023)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

Attainment of therapeutic vancomycin level within the first 24 h: Authors' response
por: Baptista, João Pedro, et al.
Publicado: (2019)

1599. AUC24 Vancomycin Bayesian-Based Dosing: Increasing Therapeutic Target Attainment with Decreased TDM Cost
por: Sabourenkov, Paul E, et al.
Publicado: (2019)

Clinical pharmacokinetics of vancomycin in the neonate: a review
por: Pacifici, Gian Maria, et al.
Publicado: (2012)

The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates
por: Samardzic, Janko, et al.
Publicado: (2016)

Impact of Pharmacist-Led Multidisciplinary Team to Attain Targeted Vancomycin Area under the Curved Monitoring in a Tertiary Care Center in Thailand
por: Jantarathaneewat, Kittiya, et al.
Publicado: (2023)

409 Efficacy of Vancomycin against Biofilms of Neonatal Staphylococcus epidermidis Bloodstream Isolates
por: Simitsopoulou, Maria, et al.
Publicado: (2014)

Attainment Targets for Protein Intake Using Standardised, Concentrated and Individualised Neonatal Parenteral Nutrition Regimens
por: Morgan, Colin, et al.
Publicado: (2019)

Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population
por: Montecatine-Alonso, Elena, et al.
Publicado: (2023)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

The clinical efficacy and safety of vancomycin loading dose: A systematic review and meta-analysis
por: Mei, Hekun, et al.
Publicado: (2019)

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19
por: Piwowarczyk, Paweł, et al.
Publicado: (2023)

775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
por: Laurent, David, et al.
Publicado: (2019)

Efficacy of 8- and 4-Session Mindfulness-Based Interventions in a Non-clinical Population: A Controlled Study
por: Demarzo, Marcelo, et al.
Publicado: (2017)

Attainment of multifactorial treatment targets among the elderly in a lipid clinic
por: Barkas, Fotios, et al.
Publicado: (2015)

A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients
por: Haseeb, Abdul, et al.
Publicado: (2022)

Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care
por: Sherer, C. Rebecca, et al.
Publicado: (2005)

Index for the appropriate vancomycin dosing in premature neonates and infants
por: Endo, Aiju, et al.
Publicado: (2021)

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
por: Padari, Helgi, et al.
Publicado: (2016)

Maternal Role Attainment in Mothers with Term Neonate: A Hybrid Concept Analysis
por: Rafii, Forough, et al.
Publicado: (2020)

In vitro efficacy of vancomycin combined with fosfomycin against Vancomycin-Resistant Enterococci strains
por: Aktas, Gulseren
Publicado: (2020)

Unemployment Hysteresis by Sex and Education Attainment in the EU
por: Cuestas, Juan Carlos, et al.
Publicado: (2023)

The Clinical Efficacy, Safety, and Tolerability of Vancomycin for the Treatment of Recurrent Clostridioides difficile Infection – A Systematic Review
por: Knudsen, Maja Johanne Søndergaard, et al.
Publicado: (2023)

Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)

Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020)

Prospective validation of neonatal vancomycin dosing regimens is urgently needed
por: Vandendriessche, Anaïs, et al.
Publicado: (2014)

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate
por: Shin, Jeong Eun, et al.
Publicado: (2015)

Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates
por: Stockmann, Chris, et al.
Publicado: (2015)

276. Vancomycin Utilization in a Neonatal Intensive Care Unit
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2018)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020)

Vancomycin is commonly under‐dosed in critically ill children and neonates
por: Sosnin, Natasha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_18cqnjbp1j8lg7j5lh7c7h2djl